Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ashlie Santaliz Casiano"'
Autor:
Rishyashring R. Iyer, Catherine C. Applegate, Opeyemi H. Arogundade, Sushant Bangru, Ian C. Berg, Bashar Emon, Marilyn Porras-Gomez, Pei-Hsuan Hsieh, Yoon Jeong, Yongdeok Kim, Hailey J. Knox, Amir Ostadi Moghaddam, Carlos A. Renteria, Craig Richard, Ashlie Santaliz-Casiano, Sourya Sengupta, Jason Wang, Samantha G. Zambuto, Maria A. Zeballos, Marcia Pool, Rohit Bhargava, H. Rex Gaskins
Publikováno v:
Heliyon, Vol 10, Iss 12, Pp e32546- (2024)
Understanding the molecular and physical complexity of the tissue microenvironment (TiME) in the context of its spatiotemporal organization has remained an enduring challenge. Recent advances in engineering and data science are now promising the abil
Externí odkaz:
https://doaj.org/article/bd413684ef534d0492f05f355dd609c3
Autor:
Ashlie Santaliz-Casiano, Dhruv Mehta, Oana C. Danciu, Hariyali Patel, Landan Banks, Ayesha Zaidi, Jermya Buckley, Garth H. Rauscher, Lauren Schulte, Lauren Ro Weller, Deanna Taiym, Elona Liko-Hazizi, Natalie Pulliam, Sarah M. Friedewald, Seema Khan, J. Julie Kim, William Gradishar, Scott Hegerty, Jonna Frasor, Kent F. Hoskins, Zeynep Madak-Erdogan
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract African American (AA) women in the United States have a 40% higher breast cancer mortality rate than Non-Hispanic White (NHW) women. The survival disparity is particularly striking among (estrogen receptor positive) ER+ breast cancer cases.
Externí odkaz:
https://doaj.org/article/beae8bb87c8d4735bd2357ef0fcaedbc
Autor:
Zeynep Madak Erdogan, Debu Tripathy, Akshara Singareeka Raghavendra, John D. O'Neill, Evelyn Aranda, Benita S. Katzenellenbogen, Yvonne Ziegler, Ben Ho Park, David J. Shapiro, Nicole Hwajin Park, Eylem Kulkoyluoglu-Cotul, Ozan Berk Imir, Jenny Drnevich, Christine Chien, Ashlie Santaliz Casiano, Yu-Jeh Liu, Ayca Nazli Mogol, Qianying Zuo
Supplementary Table from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08fcbd670914710b64958120b07b5ee2
https://doi.org/10.1158/1541-7786.22528229.v1
https://doi.org/10.1158/1541-7786.22528229.v1
Autor:
Zeynep Madak Erdogan, Debu Tripathy, Akshara Singareeka Raghavendra, John D. O'Neill, Evelyn Aranda, Benita S. Katzenellenbogen, Yvonne Ziegler, Ben Ho Park, David J. Shapiro, Nicole Hwajin Park, Eylem Kulkoyluoglu-Cotul, Ozan Berk Imir, Jenny Drnevich, Christine Chien, Ashlie Santaliz Casiano, Yu-Jeh Liu, Ayca Nazli Mogol, Qianying Zuo
Estrogen receptor–positive (ER+) metastatic tumors contribute to nearly 70% of breast cancer–related deaths. Most patients with ER+ metastatic breast cancer (MBC) undergo treatment with the estrogen receptor antagonist fulvestrant as standard of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10b4132d6b56eba42f1eb12d4ae2f62b
https://doi.org/10.1158/1541-7786.c.6545651.v1
https://doi.org/10.1158/1541-7786.c.6545651.v1
Publikováno v:
Endocrinology
Endocrine-disrupting chemicals (EDCs) are known contributors to breast cancer development. Exposures to EDCs commonly occur through food packaging, cookware, fabrics, and personal care products, as well as external environmental sources. Increasing e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::452c26e2113d208513fe02c064e1fe80
https://doi.org/10.1210/endocr/bqac034
https://doi.org/10.1210/endocr/bqac034
Autor:
Ashlie Santaliz Casiano, Zeynep Madak-Erdogan, Dhruv Meta, Jonna Frasor, Garth Rauscher, Kent Hoskins
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 32:C020-C020
Background: African American (AA) women are less likely to develop breast cancer but when they do, their mortality rates are 40% higher compared to Non-Hispanic White (NHW) women. This disparity is particularly striking among ER+ breast cancer cases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd59cfac06de028fbb1c5cc3011b1926
https://doi.org/10.1158/1538-7755.disp22-c020
https://doi.org/10.1158/1538-7755.disp22-c020
Autor:
Yu-Jeh Liu, Ozan Berk Imir, David J. Shapiro, Yvonne S. Ziegler, Qianying Zuo, Jenny Drnevich, Evelyn Aranda, Zeynep Madak-Erdogan, Ashlie Santaliz Casiano, C. Chien, Debu Tripathy, N. H. Park, A. N. Mogol, Eylem Kulkoyluoglu-Cotul, Benita S. Katzenellenbogen, Ben Ho Park, A. S. Raghavendra, John D. O’Neill
Publikováno v:
Mol Cancer Res
Estrogen receptor-positive (ER+) metastatic tumors contribute to nearly 70% of breast cancer-related deaths. Most patients with ER+ metastatic breast cancer (MBC) undergo treatment with the estrogen receptor antagonist fulvestrant (Fulv) as standard-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::194582c788d79991066b0614024b916a
https://doi.org/10.1101/2021.09.07.458711
https://doi.org/10.1101/2021.09.07.458711
Autor:
Meera Patel, Brandi Patrice Smith, Eylem Kulkoyluoglu-Cotul, Qianying Zuo, Gianluigi Rossi, Anna Maria Storniolo, Shoham Band, Jodi A. Flaws, Zeynep Madak-Erdogan, Ashlie Santaliz Casiano, Yiru C. Zhao, Rebecca L. Smith, John A. Katzenellenbogen, Natascia Marino, Kinga Wrobel, Sung Hoon Kim, Mariah L. Johnson
Publikováno v:
Cancer Research. 79:2494-2510
Obesity is a risk factor for postmenopausal estrogen receptor alpha (ERα)-positive (ER+) breast cancer. Molecular mechanisms underlying factors from plasma that contribute to this risk and how these mechanisms affect ERα signaling have yet to be el
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5edb83b04489546778099cca1cdb8743
https://doi.org/10.1158/0008-5472.can-18-2849
https://doi.org/10.1158/0008-5472.can-18-2849
Autor:
Evelyn Aranda, Brandi Patrice Smith, Rithva Ramesh, Ayca Nazli Mogol, David J. Shapiro, Ozan Berk Imir, Zeynep Madak-Erdogan, Jenna Kathryn Lee, Qianying Zuo, Mrinali P. Kesavadas, Chengjian Mao, Drew Daly, John D. O’Neill, Yosef Landesman, Ashlie Santaliz-Casiano, Elif Tunc, Monika Ziogaite, Christopher J. Walker, Eylem Kulkoyluoglu Cotul, Ben Ho Park, Kevin Duong, Benita S. Katzenellenbogen, Elijah Odukoya
Publikováno v:
Cancers
Volume 12
Issue 9
Cancers, Vol 12, Iss 2397, p 2397 (2020)
Volume 12
Issue 9
Cancers, Vol 12, Iss 2397, p 2397 (2020)
The majority of breast cancer specific deaths in women with estrogen receptor positive (ER+) tumors occur due to metastases that are resistant to therapy. There is a critical need for novel therapeutic approaches to achieve tumor regression and/or ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dd9f1c4cda89596a9545881aaf82081
Autor:
Natascia Marino, Hamdi Torun, Kaan Oktay, Zeynep Madak Erdogan, Ashlie Santaliz-Casiano, Burak Acar, Meera Patel, Anna Maria Storniolo
Publikováno v:
Hormonescancer. 11(1)
Breast cancer is the second leading cause of cancer mortality among women. Mammography and tumor biopsy followed by histopathological analysis are the current methods to diagnose breast cancer. Mammography does not detect all breast tumor subtypes, e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5a187c118077edfb96ad8dca02aba6d
https://pubmed.ncbi.nlm.nih.gov/31858384
https://pubmed.ncbi.nlm.nih.gov/31858384